Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Cerebral deposition of the beta-amyloid peptide (A beta) is an invariant feature of Alzheimer's disease. Since the original isolation and characterization of A beta (ref. 1) and the subsequent cloning of its precursor protein, no direct evidence for the actual production of discrete A beta has been reported. Here we investigate whether A beta is present in human biological fluids using antibodies specific for an epitope within A beta that spans the site of normal constitutive cleavage. These antibodies were used to construct a sandwich-type enzyme-linked immunosorbent assay that detects A beta in cerebrospinal fluid, plasma and conditioned medium of human mixed-brain cells grown in vitro (see also ref. 14). By affinity chromatography, we have purified and sequenced A beta and a novel A beta fragment from human cerebrospinal fluid and conditioned medium of human mixed-brain cell cultures. These findings demonstrate that A beta is produced and released both in vivo and in vitro. These observations offer new opportunities for developing diagnostic tests for Alzheimer's disease and therapeutic strategies aimed at reducing the cerebral deposition of A beta.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies that shed light on the physiological role of Aβ in non-diseased brains show that Aβ plays a role in synaptic transmission and is involved in learning and memory formation [18–22].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [18]
In the citing paper
“Recently, we and others have shown that normal processing of the large amyloid f3 protein precursor ({3-APP) secretes 4-kDa A(3 that is readily detected in human cerebrospinal fluid and in medium conditioned by cultured cells (3)(4)(5)(6).”
From Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain (1995) · cites this paper as [3]
In the citing paper
“The demonstration that A-related peptides with the same N terminals as the CTFs documented here are present in conditioned medium of cultured cells (Seubert et al., 1992;Naslund et al., 1994;Simons et al., 1996;Wang et al., 1996;Xu et al., 1998)”
From Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path (1998) · cites this paper as Seubert et al., 1992
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Self-citationCleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,410
Self-citationMutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,381
Self-citationChartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J., Farlow, M., Ghetti, B., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,127
Tanzi, R. E., McClatchey, A. I., Lamperti, E. D., Villa-Komaroff, L., Gusella, J. F., & Neve, R. L. (1988) · Nature · doi:10.1038/331528a0 · Cited by 1,096
Cited by
Items 901–1,000 of 1,726
Kar, S., & Quirion, R. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45018-8 · Cited by 45
A Coarse-Grained Model for Peptide Aggregation on a Membrane Surface
Morriss-Andrews, A., Brown, F. L. H., & Shea, J. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp502871m · Cited by 39
Bode, D. C., Stanyon, H. F., Hirani, T., Baker, M. D., Nield, J., & Viles, J. H. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.01.008 · Cited by 41
Search for Amyloid-Binding Proteins by Affinity Chromatography
Calero, M., Rostagno, A. A., & Ghiso, J. A. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-551-0_15 · Cited by 38
Relationship between serum α1-antichymotrypsin and Alzheimer's disease
Hinds, T. R., Kukull, W. A., van Belle, G., Schellenberg, G. D., Villacres, E. C., & Larson, E. B. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90141-4 · Cited by 37
Biochemistry of Alzheimer's disease amyloid plaques
Fraser, P. E., Lévesque, L., & McLachlan, D. R. C. (1993) · Clinical Biochemistry · doi:10.1016/0009-9120(93)90110-r · Cited by 42
Balakrishnan, M., Hussain, S., & Iyer, P. K. (2013) · Polymer Chemistry · doi:10.1039/c3py00680h · Cited by 37
Effect of amyloid peptides on serum withdrawal-induced cell differentiation and cell viability
Yi Peng, W. A. N. G., Wang, Z. F., Zhang, Y., Tian, Q., & Wang, J. Z. (2004) · Cell Research · doi:10.1038/sj.cr.7290249 · Cited by 36
Biomarkers in biological fluids for dementia with Lewy bodies
Schade, S., & Mollenhauer, B. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0072-3 · Cited by 39
“Introduction The isolation and successful detection of soluble β-amyloid (Aβ) from biological fluids in 1992 [1] revolutionized our knowledge of the connection between molecular pathology and cerebrospinal fluid (CSF) biomarkers.”
BackgroundCarelli‐Alinovi, C., Dinarelli, S., Sampaolese, B., Misiti, F., & Girasole, M. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.07.009 · Cited by 37
Fu, H., Liu, B., Li, L., & Lemere, C. A. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.07.020 · Cited by 37
“To date, most published studies used a very high concentration (~ 1 μM) of synthetic Aβ, whereas concentrations of Aβ in physiological fluids are only 0.1 – 10 nM (Podlisny et al., 1995; Seubert et al., 1992; Suzuki et al., 1994).”
BackgroundResultInfluentialEmerging Nanoporous Materials for Biomolecule Separation
Song, Y., Bao, H., Shen, X., Li, X., Liang, X., & Wang, S. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202113153 · Cited by 38
Transthyretin Accelerates Vascular Aβ Deposition in a Mouse Model of Alzheimer's Disease
Wati, H., Kawarabayashi, T., Matsubara, E., Kasai, A., Hirasawa, T., Kubota, T., Harigaya, Y., Shoji, M., & Maeda, S. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00166.x · Cited by 40
“On the other hand, recent evidence indicates that Ab is mainly cleared out of the brain to blood via transport through the blood-brain barrier, and via the interstitial fluid (ISF) bulk flow along periarterial drainage pathways into the CSF, and from there into the blood (26, 33, 52, 56).”
BackgroundInfluentialSingh, R. R. P., Barman, A., & Prabhakar, R. S. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp811154w · Cited by 40
Soluble Aβ homeostasis in AD and DS: impairment of anti-amyloidogenic protection by lipoproteins
Matsubara, E., Sekijima, Y., Tokuda, T., Urakami, K., Amari, M., Shizuka‐Ikeda, M., Tomidokoro, Y., Ikeda, M., Kawarabayashi, T., Harigaya, Y., et al. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.10.004 · Cited by 39
Computer Simulations of Alzheimers Amyloid β-Protein Folding and Assembly
Urbanc, B., Cruz, L., Teplow, D. B., & Stanley, E. (2006) · Current Alzheimer Research · doi:10.2174/156720506779025170 · Cited by 41
“edu produced, the principal species deposited within the parenchyma of the AD brain is A (1-42) [12,13].”
BackgroundDeposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro
Wujek, J. R., Dority, M. D., Frederickson, R. C. A., & Brunden, K. R. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02020-9 · Cited by 44
The Functions of the Amyloid Precursor Protein Gene
Panegyres, P. K. (2001) · Reviews in the Neurosciences · doi:10.1515/revneuro.2001.12.1.1 · Cited by 36
Lins, L., Thomas‐Soumarmon, A., Pillot, T., Vandekerckhove, J., Rosseneu, M., & Brasseur, R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730758.x · Cited by 36
“The Ab(1–40) peptide is a normal product of APP cleavage, as it is found in human CSF (Seubert et al., 1992; Shoji et al., 1992) and in the conditioned medium of a wide variety of cell cultures (Haass et al., 1992; Busciglio et al., 1993).”
BackgroundRoßner, S. (1997) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(97)00035-x · Cited by 38
Matsumoto, A., & Fujiwara, Y. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18213.x · Cited by 36
Roles for calcium signaling in structural plasticity and pathology in the hippocampal system
Mattson, M. P., & Barger, S. W. (1993) · Hippocampus · doi:10.1002/hipo.1993.4500030711 · Cited by 37
Alzheimer's disease — Recent biomarker developments in relation to updated diagnostic criteria
Höglund, K., Fourier, A., Perret‐Liaudet, A., Zetterberg, H., Blennow, K., & Portelius, E. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.01.041 · Cited by 46
Electrochemical and Conformational Consequences of Copper (CuI and CuII) Binding to β‐Amyloid(1–40)
Brzyska, M., Trześniewska, K., Wieckowska, A., Szczepankiewicz, A. A., & Elbaum, D. (2009) · ChemBioChem · doi:10.1002/cbic.200800732 · Cited by 40
Processing of β-Amyloid Precursor Protein by Cathepsin D
Higaki, J., Catalano, R., Guzzetta, A. W., Quon, D., Navé, J.-F., Tarnus, C., D'Orchymont, H., & Cordell, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31885 · Cited by 35
Kida, E., Wisniewski, K. E., & Wísniewski, H. M. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11678-p · Cited by 37
Quantification of sub-femtomole amounts of Alzheimer amyloid β peptides
Potempska, A., Mack, K., Mehta, P., Kim, K. S., & Miller, D. L. (1999) · Amyloid · doi:10.3109/13506129908993283 · Cited by 35
Steroids as γ‐secretase modulators
Jung, J. I., Ladd, T. B., Kukar, T. L., Price, A. R., Moore, B. D., Koo, E. H., Golde, T. E., & Felsenstein, K. M. (2013) · The FASEB Journal · doi:10.1096/fj.12-225649 · Cited by 39
Kulikova, A. A., Makarov, A. А., & Kozin, S. A. (2015) · Molecular Biology · doi:10.1134/s0026893315020065 · Cited by 38
“The Aβ peptide is produced in the brain in the course of normal cell metabolism, is secreted into the extracellular space, and circulates in the cerebrospinal fluid (CSF) and blood [27, 28].”
BackgroundBellaver, B., Puig‐Pijoan, A., Ferrari‐Souza, J. P., Leffa, D. T., Lussier, F. Z., Ferreira, P. C. L., Tissot, C., Povala, G., Therriault, J., Benedet, A. L., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13014 · Cited by 42
“Aβ presents brain as well as an important peripheral production (18,19).”
Kruse, N., Schulz‐Schaeffer, W., Schlossmacher, M. G., & Mollenhauer, B. (2012) · Methods · doi:10.1016/j.ymeth.2012.03.016 · Cited by 40
Huang, J. Y., Yao, Y., Lin, J., Ye, Y., Sun, W., & Tang†, W.-X. (2004) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-004-0556-x · Cited by 37
Ciulla, T. A., Tolentino, F. I., Morrow, J. F., & Dryja, T. P. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(95)80026-3 · Cited by 34
Sugihara, S., Ogawa, A., Nakazato, Y., & Yamaguchi, H. (1995) · Acta Neuropathologica · doi:10.1007/bf00294312 · Cited by 36
GOLDE, T. E., CAI, X., SHOJI, M., & YOUNKIN, S. G. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23036.x · Cited by 34
Amyloid-beta peptide affects the oxygen dependence of erythrocyte metabolism: A role for caspase 3
Clementi, M. E., Giardina, B., Colucci, D., Galtieri, A., & Misiti, F. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.11.013 · Cited by 34
Signal Transduction Therapeutics: Relevance for Alzheimer's Disease
Silva, O. A. B. D. C. E., Fardilha, M., Henriques, A. G., Rebelo, S., Vieira, S. I., & Silva, E. F. D. C. E. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:1-2:123 · Cited by 36
“Fe65 overexpression in HEK293 cells leads to inhibition of Aβ1–40 and Aβ1–42 secretion, and this effect was partially canceled by mutating Thr668.”
InfluentialAre β-sheet breaker peptides dissolving the therapeutic problem of Alzheimer’s disease?
Permanne, B., Adessi, C., Fraga, S., Frossard, M., Saborío, G. P., & Soto, C. A. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_27 · Cited by 35
Physiological levels of β-amyloid peptide stimulate protein kinase C in PC12 cells
Luo, Y., Hawver, D. B., Iwasaki, K., Sunderland, T., Roth, G. S., & Wolozin, B. L. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00718-x · Cited by 34
Zhao, H., Zhu, J., Cui, K., Xu, X., O'Brien, M., Wong, K. K., Kesari, S., Xia, W., & Wong, S. T. (2009) · Cancer Cell International · doi:10.1186/1475-2867-9-15 · Cited by 33
Kulichikhin, K. Y., Fedotov, S. A., Rubel, M. S., Zalutskaya, N. M., Zobnina, A. E., Malikova, O. A., Незнанов, Н. Г., Chernoff, Y. O., & Rubel, A. A. (2021) · Prion · doi:10.1080/19336896.2021.1917289 · Cited by 35
“Aβ42 is present in CSF [23] and its level is significantly decreased in CSF of AD patients [24], apparently”
BackgroundCerebrospinal Fluid Biomarkers for Alzheimer's Disease: More to Come?
Zetterberg, H., & Blennow, K. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129035 · Cited by 36
“be secreted to the CSF [24].”
Svobodová, Z., Mohamadi, M. R., Jankovičová, B., Esselmann, H., Verpillot, R., Otto, M., Taverna, M., Wiltfang, J., Viovy, J., & Bílková, Z. (2012) · Biomicrofluidics · doi:10.1063/1.4722588 · Cited by 38
Ferrera, D., Mazzaro, N., Canale, C., & Gasparini, L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.023 · Cited by 37
Zhao, L., Zhu, L., & Guo, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.080 · Cited by 36
Evaluation of chronic lead effects in the blood brain barrier system by DCE-CT
Gu, H., Territo, P. R., Persohn, S. A., Bedwell, A. A., Eldridge, K., Speedy, R., Chen, Z., Zheng, W., & Du, Y. (2020) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2020.126648 · Cited by 36
Wang, Y., Zhang, G., Zhou, H., Barakat, A., & Querfurth, H. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008366 · Cited by 40
“Aβ is considered to have physiological functions in part because it is normally present in cerebrospinal fluid at low levels”
BackgroundClementi, M. E., Martorana, G. E., Pezzotti, M., Giardina, B., & Misiti, F. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.03.006 · Cited by 39
Novel Therapeutic Modalities to Address Nondrugable Protein Interaction Targets
Souza, E. B. D., Cload, S. T., Pendergrast, P. S., & Sah, D. W. Y. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.115 · Cited by 35
Barritt, J. D., Younan, N. D., & Viles, J. H. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201704618 · Cited by 34
Cavani, S., Tamaoka, A., Moretti, A., Marinelli, L., Angelini, G., Stefano, S. D., Piombo, G., Cazzulo, V., Matsuno, S., Shoji, S., et al. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20001127)95:3<208::aid-ajmg5>3.0.co;2-j · Cited by 33
Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains
Pirttilä, T., Soininen, H. S., Mehta, P. D., Heinonen, O., Lehtimäki, T. J., Bogdanović, N., Paljärvi, L., Kim, K. S., Kosunen, O., Winblad, B. G., et al. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00204-7 · Cited by 36
The Amyloid Peptide and Its Precursor in Alzheimer's Disease
Octave, J. N. (1995) · Reviews in the Neurosciences · doi:10.1515/revneuro.1995.6.4.287 · Cited by 39
The Alzheimer's disease sphinx: a riddle with plaques and tangles.
Kosik, K. S. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.6.1501 · Cited by 35
Secretases as therapeutic targets for the treatment of Alzheimer's disease
Dominguez, D. I., Strooper, B. D., & Annaert, W. G. (2001) · Amyloid · doi:10.3109/13506120109007356 · Cited by 44
“106 Marcinkiewicz M and Seidah NG (2000). Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM 10 in mouse and human brain.”
BackgroundChambers, J. K., Kuribayashi, H., Ikeda, S.-I., & Une, Y. (2010) · Amyloid · doi:10.3109/13506129.2010.483119 · Cited by 32
Turn Nucleation Perturbs Amyloid β Self-Assembly and Cytotoxicity
Doran, T. M., Anderson, E. A., Latchney, S. E., Opanashuk, L. A., & Nilsson, B. L. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.055 · Cited by 32
Vetrivel, K. S., Barman, A., Chen, Y., Nguyen, P. D., Wagner, S. L., Prabhakar, R., & Thinakaran, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.260471 · Cited by 32
Sulatskaya, A. I., Rychkov, G. N., Sulatsky, M. I., Mikhailova, E. V., Melnikova, N. M., Andozhskaya, V. S., Константинович, Т. К., & Константинович, Т. К. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105513 · Cited by 36
Vascular Endothelial Barrier Dysfunction Mediated by Amyloid-β Proteins
Nagababu, E., Usatyuk, P. V., Enika, D., Natarajan, V., & Rifkind, J. M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1104 · Cited by 32
Sealy, J. M., Truong, A. P., Tso, L. S., Probst, G. D., Aquino, J., Hom, R. K., Jagodzinska, B. M., Dressen, D. B., Wone, D. W. G., Brogley, L., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.061 · Cited by 34
Self-citationSteinacker, P., Hendrich, C., Sperfeld, A., Jesse, S., Lehnert, S., Pabst, A., Arnim, C. A. F. V., Mottaghy, F. M., Uttner, I., Tumani, H., et al. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0271-4 · Cited by 37
“Cleavage by b secretase leads to the generation of sAPPb and subsequently, after cleavage by c secretase, to Ab peptides, that are secreted into the CSF (De Strooper et al. 1998, Hussain et al. 1999, Seubert et al. 1992, Sinha and Lieberburg 1999, Vassar et al. 1999).”
BackgroundLaDu, M. J., Munson, G. W., Jungbauer, L., Getz, G. S., Reardon, C. A., Tai, L. M., & Yu, C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.11.005 · Cited by 30
Zhang, S., & Janciauskiene, S. M. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4206 · Cited by 32
Kuperstein, F., Reiss, N. A., Koudinova, N. V., & Yavin, E. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00037.x · Cited by 32
“…component in AD is the amyloidb protein (Ab), a 39±43 amino acid-containing peptide the soluble form of which has been detected in vivo, in plasma, CSF and brain, indicating a possible role in normal physiological cellular functions (Seubert et al. 1992; Haass and Selkoe 1993; Tabaton et al. 1994).”
BackgroundGenetic heterogeneity of gene defects responsible for familial Alzheimer disease
Tanzi, R. E., Gaston, S. M., Bush, A. I., Romano, D., Pettingell, W. H., Peppercorn, J. M., Paradis, M. D., Gurubhagavatula, S., Jenkins, B., & Wasco, W. (1993) · Genetica · doi:10.1007/bf01436002 · Cited by 32
Sun, Y., Wright, H. T., & Janciauskiene, S. M. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10144 · Cited by 34
Efthimiopoulos, S., Felsenstein, K. M., Sambamurti, K., Robakis, N. K. R. K., & Refolo, L. M. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490380111 · Cited by 34
Cheung, N. S., Small, D. H., & Livett, B. G. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03270.x · Cited by 35
“In addition, the presence of PA, in normal human CSF argues that these fragments are normally secreted from nervous tissue; however, the functional significance of these secreted PA, fragments is not known (Seubert et al., 1992).”
BackgroundSerum- and bradykinin-induced calcium transients in familial Alzheimer's fibroblasts
McCoy, K., Mullins, R. D., Newcomb, T. G., Ng, G., Pavlínková, G., Polinsky, R. J., Nee, L. E., & Sisken, J. E. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90103-i · Cited by 32
Muscarinic agonists in Alzheimer's disease
Growdon, J. H. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00039-8 · Cited by 33
Citron, M., Haass, C., & Selkoe, D. J. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90041-9 · Cited by 31
Self-citationTau immunization: a cautionary tale?
Mably, A. J., Kanmert, D., Donald, J. M. M., Liu, W., Caldarone, B. J., Lemere, C. A., O’Nuallain, B., Kosik, K. S., & Walsh, D. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.11.022 · Cited by 33
Role of Presenilin in Mitochondrial Oxidative Stress and Neurodegeneration in Caenorhabditis elegans
Sarasija, S., & Norman, K. R. (2018) · Antioxidants · doi:10.3390/antiox7090111 · Cited by 34
“Upon γ-secretase cleavage, Aβ is liberated and then found in extracellular fluids such as plasma or cerebrospinal fluid (Seubert et al., 1992).”
BackgroundSpecificity of Adaptive Immune Responses in Central Nervous System Health, Aging and Diseases
Rickenbach, C., & Gericke, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.806260 · Cited by 37
“Since ISF-CSF flow contributes to Aβ clearance, Aβ and tau are retrievable in both CSF and peripheral blood (Seubert et al., 1992; Shibata et al., 2000; Weller et al., 2008; Zlokovic, 2011; Iliff et al., 2012).”
BackgroundLeclerc, E., Sturchler, E., Vetter, S. W., & Heizmann, C. W. (2009) · Reviews in the Neurosciences · doi:10.1515/revneuro.2009.20.2.95 · Cited by 32
Nitsch, R. M., Slack, B. E., Farber, S. A., Schulz, J. G., Deng, M., Kim, C., Borghesani, P. R., Korver, W., Wurtman, R. J., & Growdon, J. H. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9350-1_2 · Cited by 37
Gutala, R. V., Ju, W., Hwang, Y. Y., Haq, R. U., & Li, M. D. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.100 · Cited by 34
Cerebrospinal fluid Aβ40 and Aβ42: Natural course and clinical usefulness
Shoji, M., & Kanai, M. (2001) · Journal of Alzheimer's Disease · doi:10.3233/jad-2001-3306 · Cited by 31
Serine proteases and their serpin inhibitors in Alzheimer's disease
Ho, G. J., Smirnova, I. V., Akaaboune, M., Hantaï, D., & Festoff, B. W. (1994) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(94)90175-9 · Cited by 32
Pirttilä, T., Koivisto, K. J., Mehta, P. D., Reinikainen, K. J., Kim, K. S., Kilkku, O., Heinonen, E. H., Soininen, H. S., Riekkinen, P. J., & Wísniewski, H. M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00381-4 · Cited by 31
Cleavage of full-length βAPP mRNA by hammerhead ribozymes
Denman, R. B. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.17.4119 · Cited by 31
Convertases other than furin cleave β‐secretase to its mature form
Pinnix, I., Council, J. E., Roseberry, B., Onstead, L., Mallender, W., Sucic, J., & Sambamurti, K. (2001) · The FASEB Journal · doi:10.1096/fj.00-0891fje · Cited by 31
The molecular genetics of Alzheimer's disease
MULLAN, M. J., & Crawford, F. (1994) · Molecular Neurobiology · doi:10.1007/bf02816100 · Cited by 32
β-Amyloid precursor protein is detectable on monocytes and is increased in Alzheimer’s disease
Jung, S. S., Gauthier, S. G., & Cashman, N. R. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00051-2 · Cited by 35
The Search for an Amyloid Solution
Robinson, S. R., & Bishop, G. M. (2002) · Science · doi:10.1126/science.298.5595.962 · Cited by 31
Guo, X.-Y., Yi, L., Yang, J., An, H., Yang, Z., & Wang, H. (2024) · Chemical Communications · doi:10.1039/d3cc05811e · Cited by 31
Perez, F. P., Bose, D., Maloney, B., Nho, K., Shah, K., & Lahiri, D. K. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131544 · Cited by 30
“A 40 comprises 90–95% of secreted A and is the predominant species recovered from cerebrospinal fluid (CSF) [37].”
InfluentialO’Nuallain, B., Klyubin, I., Mc Donald, J. M., Foster, J. S., Welzel, A., Barry, A., Dykoski, R. K., Cleary, J. P., Gebbink, M. F. B. G., Rowan, M. J., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07389.x · Cited by 30
“Given the enormous interest in Aβ-specific antibodies as therapeutic, diagnostic, and basic research reagents, numerous antibodies have been generated and these can be grouped into 4 classes based on their ability to recognize: (1) linear epitopes (Seubert et al., 1992; Solomon et al., 1996; Jensen et al., 2000), (2)…”
BackgroundSasaki, A., Iijima, M., Yokoo, H., Shoji, M., & Nakazato, Y. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00097-8 · Cited by 30
Regulated cleavage of the Alzheimer amyloid precursor protein: Molecular and cellular basis
Gandy, S., & Greengard, P. (1994) · Biochimie · doi:10.1016/0300-9084(94)90162-7 · Cited by 30
Kinetic theory of amyloid fibril templating
Schmit, J. D. (2013) · The Journal of Chemical Physics · doi:10.1063/1.4803658 · Cited by 34
Alexopoulos, P., Tsolakidou, A. F., Roselli, F., Arnold, A., Grimmer, T., Westerteicher, C., Leante, M. R., Förstl, H., Livrea, P., Kurz, A., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.04.009 · Cited by 35
“Both sAPPa and sAPPb are secreted into the cerebrospinal fluid (CSF) in humans [18].”
BackgroundProfiling biomarkers of traumatic axonal injury: From mouse to man
Manivannan, S., Makwana, M., Ahmed, A. I., & Zaben, M. (2018) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2018.05.017 · Cited by 34
Robert, J., Button, E. B., Martin, E. M., McAlary, L., Gidden, Z., Gilmour, M., Boyce, G., Caffrey, T. M., Agbay, A., Clark, A., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00366-8 · Cited by 27
Rainer, M., Haq, M. N. U., Bakry, R. S., Huck, C. W., & Bonn, G. K. (2006) · Journal of Proteome Research · doi:10.1021/pr060426y · Cited by 30
Alzheimer's Disease, ß-Amyloidosis, and Aging
Coria, F., Rubio, I., & Bayón, C. (1994) · Reviews in the Neurosciences · doi:10.1515/revneuro.1994.5.4.275 · Cited by 39
Bickel, U., Lee, V. M. ‐., Trojanowski, J. Q., & Pardridge, W. M. (1994) · Bioconjugate Chemistry · doi:10.1021/bc00026a003 · Cited by 30
Hardy, J., & Mullan, M. (1992) · Nature · doi:10.1038/359268a0 · Cited by 31
Cellular and molecular basis of beta-amyloid precursor protein metabolism
Xu, H. (1998) · Frontiers in Bioscience · doi:10.2741/a283 · Cited by 2
Metadata
- Authors
- Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I., & Schenk, D.
- Affiliations
- Austrian Academy of Sciences (AT)
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6393
- Pages
- 325-327
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2086278983
- Cited by
- 1,731
- References
- 28
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 32 · 2023: 19 · 2022: 22 · 2021: 31 · 2020: 28 · 2019: 25 · 2018: 35 · 2017: 39 · 2016: 31 · 2015: 48 · 2014: 46 · 2013: 39 · 2012: 50
- FWCI
- 72.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, cerebrospinal fluid, plasma, conditioned medium, sandwich ELISA, affinity chromatography, epitope-specific antibodies, amyloid deposition, diagnostic biomarkers
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Antibodies, Monoclonal, Brain, Cells, Cultured, Cross Reactions, Enzyme-Linked Immunosorbent Assay, Humans, Molecular Sequence Data, Peptide Fragments, Radioimmunoassay, Solubility, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.